フォローフィードコミュニティでトレーダーや投資家とつながりましょう.
包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.
ターミナル モニターで株式と資産のウォッチリストを整理および監視します
Johnson & Johnson on Tuesday predicted "competitive growth" in the key fields in the year to come, and adding that it ...
Johnson & Johnson over the weekend announced the results of a number of different clinical trials focused on various ...
Johnson & Johnson on Tuesday said it delivered a "strong" set of results in the third quarter of 2023, as it reported ...
- New Brunswick, New Jersey-based pharmaceutical company - Submits a type two extension of indication application to ...
Major drugmakers have grudgingly agreed to negotiate on reducing prices for 10 medicines, the White House said Tuesda ...
Johnson & Johnson on Thursday said its subsidiary Janssen it has decided to stop the Phase 3 MACiTEPH study evaluatin ...
Johnson & Johnson on Wednesday revised guidance for the full-year as it looked ahead to life without its consumer-hea ...
- New Brunswick, New Jersey-based pharmaceutical and consumer goods firm - US Food & Drug Administration approves Tal ...
Johnson & Johnson on Thursday raised its full-year guidance after reporting a "robust" second quarter, with solid ris ...
Johnson & Johnson on Tuesday said its subsidiary Janssen has submitted a new drug application to the US Food & Drug A ...
Johnson & Johnson on Tuesday said phase 3 data for its Tremfya treatments showed positive results for patients with m ...
- New Brunswick, New Jersey-based pharmaceutical and consumer goods firm - Announces initial public offering pricing ...
Johnson & Johnson on Sunday said its wholly-owned subsidiary Janssen Pharmaceutical Co has announced the first result ...
Johnson & Johnson on Tuesday said it swung to a loss in the first quarter of 2023, despite sales ticking up, as it re ...
US pharmaceutical company Johnson & Johnson on Tuesday proposed an USD8.9 billion settlement to resolve years-old law ...
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約